A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes (PRONTO-Pump)

The purpose of this study is to evaluate the compatibility and safety of LY900014 and insulinlispro with an insulin pump in adults with type 1 diabetes.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Type 1 Diabetes
What the trial is testing?
Insulin lispro, LY900014
Could I receive a Placebo?
No
Enrollment Goal
49
Trial Dates
Feb 21, 2018 - Sep 4, 2018
How long will I be in the trial?
Your participation could last about 19 weeks and include up to 10 visits to the study center.
Trial Phase
III

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.